Registration number:
My Health Journal (UK) Ltd
for the Period from 9 September 2024 to 30 September 2025
My Health Journal (UK) Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
My Health Journal (UK) Ltd
Company Information
|
Director: |
Mr R Sethi |
|
Registered office: |
|
|
Registered number: |
15946003 |
|
Accountants: |
|
My Health Journal (UK) Ltd
(Registration number: 15946003)
Balance Sheet as at 30 September 2025
|
Note |
30.09.25 |
||
|
£ |
£ |
||
|
FIXED ASSETS |
|||
|
Intangible assets |
|
||
|
Tangible assets |
|
||
|
|
|||
|
CURRENT ASSETS |
|||
|
Cash at bank and in hand |
|
||
|
CREDITORS |
|||
|
Creditors within 1yr |
51,688 |
||
|
Net current liabilities |
( |
||
|
Net liabilities |
( |
||
|
CAPITAL AND RESERVES |
|||
|
Called up share capital |
1 |
||
|
Profit and loss account |
(13,015) |
||
|
Shareholders' deficit |
(13,014) |
||
For the financial period ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
......................................... |
My Health Journal (UK) Ltd
Notes to the Unaudited Financial Statements for the Period from 9 September 2024 to 30 September 2025
|
1. |
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
|
2. |
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
The presentational currency is Pound Sterling (£).
Going concern
The financial statements have been prepared on a going concern basis on the understanding that the director and related parties will continue to support the business for at least 12 months from the date of signing the financial statements.
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
My Health Journal (UK) Ltd
Notes to the Unaudited Financial Statements for the Period from 9 September 2024 to 30 September 2025 (continued)
|
2 |
Accounting policies (continued) |
Intangible assets
Separately acquired trademarks and licences are shown at historical cost.
Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.
Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.
Amortisation
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
|
3. |
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
My Health Journal (UK) Ltd
Notes to the Unaudited Financial Statements for the Period from 9 September 2024 to 30 September 2025 (continued)
|
4. |
Intangible assets |
|
Trademarks, patents and licenses |
Total |
|
|
Cost or valuation |
||
|
Additions internally developed |
|
|
|
At 30 September 2025 |
|
|
|
Amortisation |
||
|
Carrying amount |
||
|
At 30 September 2025 |
|
|
|
5. |
Tangible assets |
|
Office equipment |
Total |
|
|
Cost or valuation |
||
|
Additions |
|
|
|
At 30 September 2025 |
|
|
|
Depreciation |
||
|
Charge for the period |
|
|
|
At 30 September 2025 |
|
|
|
Carrying amount |
||
|
At 30 September 2025 |
|
|
|
6. |
Creditors |
Creditors: amounts falling due within one year
My Health Journal (UK) Ltd
Notes to the Unaudited Financial Statements for the Period from 9 September 2024 to 30 September 2025 (continued)
|
6 |
Creditors (continued) |
|
30.09.25 |
|
|
Due within one year |
|
|
Accruals and deferred income |
|
|
Other creditors |
|
|
|
Included in other creditors is £50,248 owed to the director on which no interest or repayment terms have been set.